高 艳,刘 君,李嘉琦,刘浩宇,陈 亮.Ⅱ期心脏康复方案对心脏瓣膜置换术患者心肺功能、运动耐力及生活质量的影响[J].现代生物医学进展英文版,2023,(5):855-858. |
Ⅱ期心脏康复方案对心脏瓣膜置换术患者心肺功能、运动耐力及生活质量的影响 |
Effects of Phase Ⅱ Cardiac Rehabilitation Program on Cardiopulmonary Function, Exercise Endurance and Quality of Life in Patients Undergoing Cardiac Valve Replacement |
Received:October 08, 2022 Revised:October 30, 2022 |
DOI:10.13241/j.cnki.pmb.2023.05.011 |
中文关键词: Ⅱ期心脏康复方案 心脏瓣膜置换术 心肺功能 运动耐力 生活质量 |
英文关键词: Phase II cardiac rehabilitation program Cardiac valve replacement Cardiopulmonary function Exercise endurance Quality of life |
基金项目:北京市科学技术委员会科研计划项目(D191100000412004) |
|
Hits: 604 |
Download times: 364 |
中文摘要: |
摘要 目的:观察Ⅱ期心脏康复方案对心脏瓣膜置换术患者心肺功能、运动耐力及生活质量的影响。方法:选择自2018年3月到2021年3月期间我院接收的120例心脏瓣膜置换术患者,根据随机数字表法将患者分为对照组(60例,围术期常规康复干预)和观察组(60例,在对照组基础上给予Ⅱ期心脏康复方案)。观察两组运动耐力、心肺功能及生活质量,记录两组随访期间心血管不良事件发生率。结果:干预2个月后,两组峰值摄氧量(VO2peak)、无氧阈时摄氧量(VO2at)、无氧阈时代谢当量(METat)、氧脉搏(O2pulse)均升高,且观察组高于对照组(P<0.05)。干预2个月后,两组Fugl-Meyer运动量表(FMA)评分升高、6 min步行试验距离(6MWT)增加,且观察组高于对照组(P<0.05)。干预2个月后,两组总体健康(GH)、生命活力(VT)、躯体疼痛(BP)、社会功能(SF)、心理健康(MH)、生理职能(RP)、生理功能(PF)、情感职能(RE)评分均升高,且观察组较对照组高(P<0.05)。与对照组比较,观察组心血管不良事件发生率降低(P<0.05)。结论:Ⅱ期心脏康复方案应用于心脏瓣膜置换术患者,可改善心肺功能,提高运动耐力及生活质量,降低心血管不良事件发生率。 |
英文摘要: |
ABSTRACT Objective: To observe the effect of phase II cardiac rehabilitation program on cardiopulmonary function, exercise endurance and quality of life in patients undergoing cardiac valve replacement. Methods: 120 patients with cardiac valve replacement who were received in our hospital from March 2018 to March 2021 were selected, the patients were divided into the control group (n=60, received routine rehabilitation intervention during the perioperative period) and the observation group (n=60, received phase II cardiac rehabilitation program on this basis of the control group) according to the random number table. The exercise endurance, cardiopulmonary function and quality of life were observed in the two groups, and the incidence of cardiovascular adverse events during the follow-up period was recorded. Results: 2 months after intervention, peak oxygen uptake (VO2peak), oxygen uptake at anaerobic threshold (VO2at), metabolic equivalent at anaerobic threshold (METat) and oxygen pulse (O2pulse) increased in the two groups, and that in the observation group was higher than that in the control group(P<0.05). 2 months after intervention, the scores of Fugl-Meyer exercise scale (FMA) increased and the distance of 6-min walking test(6MWT) increased in the two groups, and that in the observation group was higher than that in the control group (P<0.05). 2 months after intervention, the scores of general health (GH), vitality (VT), physical pain (BP), social function (SF), mental health (MH), physiological function (RP), physiological function (PF), emotional function (RE) were all increased in the two groups, and that in the observation group was higher than that in the control group (P<0.05). Compared with the control group, the incidence of cardiovascular adverse events in the observation group decreased(P<0.05). Conclusion: The phase II cardiac rehabilitation program applied to patients undergoing cardiac valve replacement, which can improve cardiopulmonary function, improve exercise endurance and quality of life, and reduce the incidence of cardiovascular adverse events. |
View Full Text
View/Add Comment Download reader |
Close |
|
|
|